Search Results

Filter
  • 1-10 of  254 results for ""Cyclooxygenase 2 Inhibitors""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*adverse effects ; Arthritis/Arthritis/Arthritis/*drug therapy ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*chemically induced

  • Source: The New England journal of medicine [N Engl J Med] 2016 Dec 29; Vol. 375 (26), pp. 2519-29. Date of Electronic Publication: 2016 Nov 13.Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A comparative study to evaluate the cardiovascular risk of selective and nonselective cyclooxygenase inhibitors (COX-Is) in arthritic patients.

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*adverse effects ; Arthritis/Arthritis/Arthritis/*drug therapy ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*adverse effects

  • Source: Journal of basic and clinical physiology and pharmacology [J Basic Clin Physiol Pharmacol] 2015 Jan; Vol. 26 (1), pp. 73-9.Publisher: Walter de Gruyter Country of Publication: Germany NLM ID: 9101750 Publication Model: Print Cited Medium: Internet ISSN: 2191-0286

Record details

×
Academic Journal

Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients.

Subjects: Arthritis/Arthritis/Arthritis/*drug therapy ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*chemically induced ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*adverse effects

  • Source: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc [Ann Noninvasive Electrocardiol] 2014 Jan; Publisher: Wiley Periodicals, Inc Country of Publication: United States NLM ID: 9607443 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Celecoxib: a review of its use in the management of arthritis and acute pain.

Subjects: Arthritis/Arthritis/Arthritis/*drug therapy ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*therapeutic use ; Pain/Pain/Pain/*drug therapy

  • Source: Drugs [Drugs] 2007; Vol. 67 (16), pp. 2433-72.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

[Lumiracoxib--Prexigem].

Subjects: Arthritis/Arthritis/Arthritis/*drug therapy ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*therapeutic use ; Diclofenac/Diclofenac/Diclofenac/*analogs & derivatives

  • Source: Journal de pharmacie de Belgique [J Pharm Belg] 2007; Vol. 62 (3), pp. 95-6.Publisher: Nationale Pharmaceutique Country of Publication: Belgium NLM ID: 0375351 Publication Model: Print Cited Medium: Print ISSN: 0047-2166

Record details

×
Academic Journal

Determination of two COX-2 inhibitors in serum and synovial fluid of patients with inflammatory arthritis by ultra performance liquid chromatography-inductively coupled plasma mass spectroscopy and quadrupole time-of-flight mass spectrometry.

  • Authors : Gika HG; Laboratory of Analytical Chemistry, Department of Chemistry, Aristotle University, 54124 Thessaloniki, Greece. ; Theodoridou A

Subjects: Arthritis/Arthritis/Arthritis/*metabolism ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*analysis ; Pyrazoles/Pyrazoles/Pyrazoles/*analysis

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2009 Apr 05; Vol. 49 (3), pp. 579-86. Date of Electronic Publication: 2008 Dec 13.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups.

  • Authors : Solomon DH; Brigham and Women's Hospital, 1620 Tremont Street, Boston, MA 02120, USA. ; Glynn RJ

Subjects: Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/Anti-Inflammatory Agents, Non-Steroidal/*adverse effects ; Antirheumatic Agents/Antirheumatic Agents/Antirheumatic Agents/*adverse effects ; Arthritis/Arthritis/Arthritis/*drug therapy

  • Source: Arthritis and rheumatism [Arthritis Rheum] 2008 Aug 15; Vol. 59 (8), pp. 1097-104.Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 0370605 Publication Model: Print Cited Medium: Print ISSN: 0004-3591

Record details

×
Academic Journal

Gastrointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review.

  • Authors : Rostom A; Division of Gastroenterology, University of Calgary, Calgary, Alberta, Canada. ; Muir K

Subjects: Arthritis/Arthritis/Arthritis/*drug therapy ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*adverse effects ; Gastrointestinal Diseases/Gastrointestinal Diseases/Gastrointestinal Diseases/*chemically induced

  • Source: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2007 Jul; Vol. 5 (7), pp. Publisher: W.B. Saunders for the American Gastroenterological Association Country of Publication: United States NLM ID: 101160775 Publication Model:

Record details

×
Periodical

Few options available for arthritis pain relief. FDA declines to approve Merck's Arcoxia.

Subjects: United States Food and Drug Administration*; Arthritis/Arthritis/Arthritis/*drug therapy ; Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/Cyclooxygenase 2 Inhibitors/*adverse effects

  • Source: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists [Am J Health Syst Pharm] 2007 May 15; Vol. 64 (10), pp. Publisher: Oxford University Press Country of Publication: England NLM ID: 9503023 Publication Model: Print Cited Medium: Print ISSN: 1079-2082

Record details

×
  • 1-10 of  254 results for ""Cyclooxygenase 2 Inhibitors""